Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and health utilities index

Medical Care

Volumn 43, Issue 11, 2005, Pages 1078-1086

  Luo, Nan ^a   Johnson, Jeffrey A ^b   Shaw, James W ^c   Feeny, David ^b,d   Coons, Stephen Joel ^e  

^a QualityMetric Incorporated   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d Health Utilities Incorporated   (Canada)

^e UNIVERSITY OF ARIZONA   (United States)

Author keywords

EQ 5D; Health status; HUI; Population health; Survey

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; QUESTIONNAIRE; RACE; SELF DISCLOSURE; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICS; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CONTINENTAL POPULATION GROUPS; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HEALTH STATUS INDICATORS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SELF DISCLOSURE; SEX FACTORS; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 27744554640     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000182493.57090.c1     Document Type: Article

References (48)

1. Kind P, Hardman G, Macran S. UK population norms for EQ-5D. Discussion Paper 172, Centre for Health Economics, The York University; 999.
2. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53-72.
3. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337-343.
4. Torrance GW, Feeny DH, Furlong WJ, et al. Multi-attribute utility function for a comprehensive health status classification system. Med Care. 1996;34:702-722.
5. Feeny DH, Furlong WJ, Torrance GW, et al. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med Care. 2002;40:113-128.
6. Brooks R, Rabin R, de Charro F, eds. The Measurement and Valuation of Health Status Using EQ-5D: A European Perspective. Dordrecht: Kluwer Academic Publishers; 2003.
7. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1:54.
8. Gold MR, Patrick DL, Torrance GW, et al. Identifying and valuing outcomes. In: Gold MR, Siegel JE, Russell LB, et al, eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996:82-134.
9. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Cost-utility analysis. In: Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. Oxford: Oxford University Press; 1997:139-199.
10. Johnson JA, Coons SJ, Ergo A, et al. Valuation of EuroQOL (EQ-5D) health states in an adult US sample. Pharmacoeconomics. 1998;13:421-433.
11. Johnson JA, Coons SJ. Comparison of the EQ-5D and SF-12 in an adult US sample. Qual Life Res. 1998;7:155-166.
12. MEPS Fact Sheet. February 2001. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.meps.ahrq.gov/whatismeps/ bulletin.htm. Accessed August 18, 2005.
13. Cohen SB. Design strategies and innovations in the Medical Expenditure Panel Survey. Med Care. 2003;41(Suppl):5-12.
14. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203-220.
15. Feeny DH, Torrance GW, Furlong WJ. Health Utilities Index. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1996:239-252.
16. Translation process. The EuroQol Group, http://www.euroqol.org/. Accessed August 18, 2005.
17. Questionnaire Development, Translations and Support. Health Utilities Inc. http://www.healthutilities.com/. Accessed August 18, 2005.
18. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life in clinical trials in chronic lung disease. Thorax. 1987;42:773-778.
19. Juniper EF, Guyatt GH, Jaeschke R. How to develop and validate a new health-related quality of life instrument. In Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1996:49-56.
20. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17:13-35.
21. Kopec JA, Willison KD. A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol. 2003;56:317-325.
22. Stewart AL, Napoles-Springer A. Health-related quality-of-life assessments in diverse population groups in the United States. Med Care. 2000;38(Suppl):II102-II124.
23. Badia X, Schiaffino A, Alonso J, Herdman M. Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity. Qual Life Res. 1998;7:311-322.
24. Burstrom K, Johannesson M, Diderichsen F. Swedish population health-related quality of life results using the EQ-5D. Qual Life Res. 2001;10:621-635.
25. Kopec JA, Williams JI, To T, Austin PC. Measuring population health: correlates of the Health Utilities Index among English and French Canadians. Can J Public Health. 2000;91:465-470.
26. Belanger A, Berthelot JM, Guimond E, et al. A head-to-head comparison of two generic health status measures in the household population: McMaster Health Utilities Index (Mark 3) and the EQ-5D. Final report, Statistics Canada; 2000.
27. Hawthorne G, Richardson J, Day NA. A comparison of the Assessment of Quality of Life (AQoL) with four other generic utility instruments. Ann Med. 2001;33:358-370.
28. Fleishman JA, Lawrence WF. Demographic variation in SF-12 scores: true differences or differential item functioning? Med Care. 2003;41(Suppl):III75- III86.
29. Hajat A, Lucas JB, Kington R. Health outcomes among Hispanic subgroups: data from the National Health Interview Survey, 1992-95. Adv Data. 2000;310:1-14.
30. Shetterly SM, Baxter J, Mason LD, Hamman RF. Self-rated health among Hispanic vs non-Hispanic white adults: the San Luis Valley Health and Aging Study. Am J Public Health. 1996;86:1798-1801.
31. Gibson RC. Race and the self-reported health of elderly persons. J Gerontol. 1991;46:S235-S242.
32. Jordan JM, Luta G, Renner JB, et al. Ethnic differences in self-reported functional status in the rural south: the Johnston County Osteoarthritis Project. Arthritis Care Res. 1996;9:483-491.
33. Villa VM, Harada ND, Washington D, et al. The health and functional status of US veterans aged 65+: implications for VA health programs serving an elderly, diverse veteran population. Am J Med Qual. 2003;18:108-116.
34. Cunningham WE, Hays RD, Burton TM, Kington RS. Health status measurement performance and health status differences by age, ethnicity, and gender: assessment in the medical outcomes study. J Health Care Poor Underserved. 2000;11:58-76.
35. Bjorner JB, Kreiner S, Ware JE, et al. Differential item functioning in the Danish translation of the SF-36. J Clin Epidemiol. 1998;51:1189-1202.
36. Clauser BE, Mazor KM. Using statistical procedures to identify differentially functioning test items. An ITEMS module of the National Council on Measurement in Education. Available at: http://www.ncme.org/pubs/items.ace. Accessed August 18, 2005.
37. Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Med. 2001;33:344-349.
38. Sanmartin C, Ng E, Blackwell D, Gentleman J, Martinez M, Simile C. Joint Canada/United States survey of health, 2002-03. Statistics Canada Catalogue 82M0022-XIE. Ottawa: Minister of Industry; 2004.
39. Grootendorst P, Feeny D, Furlong W. Does it matter whom and how you ask? An investigation into inter- and intra-rater agreement in the 1990 Ontario Health Survey. J Clin Epidemiol. 1997;50:127-135.
40. Luo N, Chew LH, Fong KY, et al. A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. J Rheumatol. 2003;30:2268-2274.
41. Lubetkin EI, Gold MR. Areas of decrement in health-related quality of life (HRQL): comparing the SF-12, EQ-5D, and HUI 3. Qual Life Res. 2003;12:1059-1067.
42. Macran S, Weatherly H, Kind P. Measuring population health: a comparison of three generic health status measures. Med Care. 2003;41:218-231.
43. Glick HA, Polsky D, Willke RJ, Schulman KA. A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index. Med Decis Making. 1999;19:265-275.
44. Bosch JL, Hunink MG. Comparison of the Health Utilities Index Mark 3 (HU13) and the EuroQol EQ-5D in patients treated for intermittent claudication. Qual Life Res. 2000;9:591-601.
45. Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care. 2003;41:791-801.
46. Stalmeier PF, Goldstein MK, Holmes AM, et al. What should be reported in a methods section on utility assessment? Med Decis Making. 2001;21:200-207.
47. Johnson JA, Ohinmaa A, Murti B, et al. Comparison of Finnish- and US-based VAS valuations of the EQ-5D. Med Decis Making. 2000;20:281-289.
48. Johnson JA, Luo N, Shaw JW, Kind P, Coons SJ. Valuations of EQ-5D health states: are the US and UK different? Med Care. 2005;43:221-228.